Trademark Overview
On Saturday, April 26, 2025, a trademark application was filed for MYELARIS with the United States Patent and Trademark Office. The USPTO has given the MYELARIS trademark a serial number of 99156700. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, April 26, 2025. This trademark is owned by Kalina Therapeutics, Inc.. The MYELARIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders